An estimate of asthma prevalence in Africa: a systematic analysis by Adeloye, Davies et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An estimate of asthma prevalence in Africa: a systematic
analysis
Citation for published version:
Adeloye, D, Chan, KY, Rudan, I & Campbell, H 2013, 'An estimate of asthma prevalence in Africa: a
systematic analysis' Croatian Medical Journal, vol. 54, no. 6, pp. 519-531. DOI: 10.3325/cmj.2013.54.519
Digital Object Identifier (DOI):
10.3325/cmj.2013.54.519
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Croatian Medical Journal
Publisher Rights Statement:
Open Access. CMJ permits and encourages authors to post items submitted to the journal on personal websites
or intitutional repositories both prior to and after publication
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
519
www.cmj.hr
Aim To estimate and compare asthma prevalence in Af-
rica in 1990, 2000, and 2010 in order to provide informa-
tion that will help inform the planning of the public health 
response to the disease.
Methods We conducted a systematic search of Medline, 
EMBASE, and Global Health for studies on asthma pub-
lished between 1990 and 2012. We included cross-section-
al population based studies providing numerical estimates 
on the prevalence of asthma. We calculated weighted 
mean prevalence and applied an epidemiological model 
linking age with the prevalence of asthma. The UN popula-
tion figures for Africa for 1990, 2000, and 2010 were used to 
estimate the cases of asthma, each for the respective year.
Results Our search returned 790 studies. We retained 45 
studies that met our selection criteria. In Africa in 1990, 
we estimated 34.1 million asthma cases (12.1%; 95% con-
fidence interval [CI] 7.2-16.9) among children <15 years, 
64.9 million (11.8%; 95% CI 7.9-15.8) among people aged 
<45 years, and 74.4 million (11.7%; 95% CI 8.2-15.3) in the 
total population. In 2000, we estimated 41.3 million cas-
es (12.9%; 95% CI 8.7-17.0) among children <15 years, 82.4 
million (12.5%; 95% CI 5.9-19.1) among people aged <45 
years, and 94.8 million (12.0%; 95% CI 5.0-18.8) in the total 
population. This increased to 49.7 million (13.9%; 95% CI 
9.6-18.3) among children <15 years, 102.9 million (13.8%; 
95% CI 6.2-21.4) among people aged <45 years, and 119.3 
million (12.8%; 95% CI 8.2-17.1) in the total population in 
2010. There were no significant differences between asth-
ma prevalence in studies which ascertained cases by writ-
ten and video questionnaires. Crude prevalences of asth-
ma were, however, consistently higher among urban than 
rural dwellers.
Conclusion Our findings suggest an increasing preva-
lence of asthma in Africa over the past two decades. Due 
to the paucity of data, we believe that the true prevalence 
of asthma may still be under-estimated. There is a need for 
national governments in Africa to consider the implica-
tions of this increasing disease burden and to investigate 
the relative importance of underlying risk factors such as 
rising urbanization and population aging in their policy 
and health planning responses to this challenge.
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Chronic respiratory diseases (CRDs) are among the leading 
causes of death worldwide, with asthma rated the most 
common chronic disease affecting children (1). Globally, 
about 300 million people have asthma, and current trends 
suggest that an additional 100 million people may be living 
with asthma by 2025 (1,2). The World Health Organization 
(WHO) estimates about 250 000 deaths from asthma every 
year, mainly in low- and middle-income countries (LMIC) 
(3,4). Just like with many other chronic diseases in Africa, 
the fast rate of urbanization has been linked to the increase 
in the burden of asthma and other allergic diseases (3,5,6). 
The prevalence of these conditions may, in theory, have 
the potential to reach levels higher than those observed 
in high-income countries (HIC) due to priming effects of 
parasitic helminthic infections on the immune system, as 
these infections are common in many African settings (5). 
The International Study of Asthma and Allergies (ISAAC) 
reported that asthma prevalence among children was in-
creasing in Africa and has contributed most to the burden 
of disease through its effects on quality of life (3). In-patient 
admissions and purchase of medications account for most 
of the direct costs on government, while loss of productiv-
ity, due to absenteeism from work and school, are respon-
sible for most of the indirect costs (7,8).
Asthma is widely known as a multifactorial respiratory dis-
order with both genetic and environmental underlying risk 
factors (3). Exposure to common allergens (including pol-
lens, dust mites, and animal furs) and indoor and outdoor 
air pollution from various sources (eg, traffic pollution, 
combustion of fossils and biomass fuels, workplace dust) 
have all been implicated as triggers of the disease (9). Sec-
ond hand tobacco smoking is a confirmed risk factor in pe-
diatric patients (5,10). Viral infections, a major cause of up-
per respiratory tract infections and “common cold,” are also 
a common risk factor in children (11,12). As noted, helmin-
thic infections are relatively common in Africa and are as-
sociated with bronchial hyper-responsiveness and asthma 
(5,13); this is perhaps due to the presence of related raised 
immunoglobulin E (IgE) and a prominent Th2 immune re-
sponse (5,14).
Studies on asthma are few in Africa, with most publica-
tions mainly from South African and Nigerian populations 
(14). One main factor affecting research output is the di-
agnosis of asthma, which still remains a challenging issue 
(15,16). The WHO has emphasized that this has limited 
on-going research efforts globally (4,16). The Interna-
tional Union against Tuberculosis and Lung Diseases 
(IUATLD) published one of the first diagnostic and 
survey guidelines for asthma in 1984, but experts subse-
quently reported concerns about its precision and reli-
ability (17). According to the Global Initiative for Asthma 
(GINA), detailed history, physical examination and spiro-
metric lung function tests are vital to the diagnosis and 
management of asthma (10,18). Generally, a reduction in 
forced expiratory volume in one second (FEV
1) and peak 
expiratory flow (PEF) may be indicative of asthma, with the 
amount of reduction proportional to the severity of asth-
ma (4). GINA proposed that an increase in FEV1 of >12% 
and 200 mL in about 15-20 minutes following the inhala-
tion of 200-400 µg of salbutamol or a 20% increase in PEF 
from baseline can be employed as standardized criteria in 
diagnosis of asthma (10). This, however, lacks sensitivity, 
as many asthmatics, especially those on treatment, may 
not exhibit an increase in FEV1 and PEF when assessed 
(16,19). Thus, although asthma is characterized by signifi-
cant reversibility of airway obstruction, an absence of re-
versibility may not always exclude the presence of asthma 
(20). The ISAAC established in 1991, remains the largest 
epidemiological study among children globally (1). ISAAC 
methodologies and scoring are currently the most widely 
employed by researchers in Africa (1,4). This involves both 
video and written questionnaires, as there were reports 
that video and pictorial representations of asthma symp-
toms may contribute to improved case recognition in 
younger children (1). However, this is still a subject of de-
bate among experts (21). The European Community Re-
spiratory Health Survey (ECRHS), which assessed the prev-
alence of atopy and symptoms of airway disease among 
older age groups in Western Europe, has been widely im-
plemented and has reported significant geographic varia-
tions in the prevalence of asthma and atopy (9). Despite 
these revised guidelines, both ISAAC and ECRHS research 
groups have reported challenges in achieving high sensi-
tivity and specificity in case ascertainment with the symp-
tom “wheeze at rest in the last 12 months” (also regarded 
as current wheeze, or active wheeze), yielding the highest 
sensitivity and specificity (1).
In Africa, problems including those arising from the over-
utilization of health services, lack of trained staff and diag-
nostic apparatus, and non-availability and unaffordability 
of inhaled medications have hindered efforts to improve 
the management of asthma (22,23). The lack of organized 
health promotion programs, such as effective control strat-
egies for environmental triggers, air pollutants, and occu-
pational dusts have also contributed to the growing bur-
den (24). The WHO has reported that the levels of asthma 
control and health responses in the continent have been 
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below recommended standards, and that these have con-
tributed to the size of the disease burden (3,4). In addition, 
although many African countries have national guidelines 
for the management of asthma and other CRDs, these 
guidelines have not been implemented in most rural areas 
(25,26). Economic analyses in many African settings have 
shown that direct costs from asthma are usually greater 
than the indirect costs. However, indirect costs represent a 
relatively higher proportion of total costs among pediatric 
than adult patients (8). Moreover, the wider economic bur-
den on individuals, families, employers, and society, due to 
loss of future potential source of livelihood, has also been 
devastating in many resource-poor settings (22). It is be-
lieved that many children with asthma in Africa may fail to 
achieve their full potential if proper management and con-
trol measures are not put in place (1). It has been suggest-
ed that education of health care providers and the public 
is a vital element of the response to the challenge posed 
by asthma in Africa (4,27).
By 2015, it is expected that world’s urban population will 
increase from 45% to 59%, with over half of this occurring 
in Africa (8). It is also expected that the prevalence of asth-
ma and many chronic diseases in Africa will increase due to 
this growing population size and from effects of accompa-
nying urbanization and adoption of western lifestyles (28). 
In light of this and of the low research output and poor 
availability of health services data on the burden of asth-
ma in Africa, it is important to analyze the available data 
through a systematic review of the literature in order to 
attempt to quantify the burden, guide health priority set-
tings, and inform the formulation of an appropriate health 
policy response.
METHODS
Search strategy and selection criteria
We conducted a systematic search of Medline, EMBASE, 
and Global Health. After an initial scoping exercise to 
identify Medical Subject Headings (MESH) and keywords, 
we developed a final search strategy. We further hand-
searched reference lists of retained publications for more 
relevant studies. African countries were included as con-
tained in the World Bank list of economies from July 2012 
(29) (Table 1).
We retained cross-sectional population-based studies on 
asthma conducted primarily on African population groups. 
The date of publication was set from 1990 to June 2013. 
We included studies providing numerical estimates on the 
prevalence of asthma, including non-English publications. 
We excluded studies that were mainly reviews, hospital-
based (without a denominator population estimate), with-
out numerical estimates, and conducted on non-human 
subjects.
Studies were further checked for clear diagnostic criteria 
and survey methods. As noted above, asthma has been 
described in various ways by many researchers, we there-
fore allowed for these variations in our analysis (Table 2 and 
Supplementary Table 1). However, most survey methods 
were mainly based on written or video questionnaires, as 
proposed by the ISAAC study group (Table 3 and Supple-
mentary Table 1).
Data extraction and analysis
Relevant data were extracted from retained studies and 
saved in Microsoft Excel file-format. All data were double 
TAblE 1. Search terms used in the study
1 africa/ or exp africa, northern/ or exp algeria/ or exp egypt/ 
or exp libya/ or exp morocco/ or exp tunisia/ or exp “africa 
south of the sahara”/ or exp africa, central/ or exp cameroon/ 
or exp central african republic/ or exp chad/ or exp congo/ 
or exp “democratic republic of the congo”/ or exp equato-
rial guinea/ or exp gabon/ or exp africa, eastern/ or exp 
burundi/ or exp djibouti/ or exp eritrea/ or exp ethiopia/ or 
exp kenya/ or exp rwanda/ or exp somalia/ or exp sudan/ or 
exp tanzania/ or exp uganda/ or exp africa, southern/ or exp 
angola/ or exp botswana/ or exp lesotho/ or exp malawi/ or 
exp mozambique/ or exp namibia/ or exp south africa/ or 
exp swaziland/ or exp zambia/ or exp zimbabwe/ or exp af-
rica, western/ or exp benin/ or exp burkina faso/ or exp cape 
verde/ or exp cote d’ivoire/ or exp gambia/ or exp ghana/ 
or exp guinea/ or exp guinea-bissau/ or exp liberia/ or exp 
mali/ or exp mauritania/ or exp niger/ or exp nigeria/ or exp 
senegal/ or exp sierra leone/ or exp togo/
2 exp vital statistics/ or exp incidence/
3 (incidence* or prevalence* or morbidity or mortality).tw.
4 (disease adj3 burden).tw.
5 exp “cost of illness”/
6 exp quality-adjusted life years/
7 QALY.tw.
8 Disability adjusted life years.mp.
9 (initial adj2 burden).tw.
10 exp risk factors/
11 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12 exp asthma/ or exp asthma, aspirin-induced/ or exp asthma, 
exercise-induced/ or exp asthma, occupational/ or exp 
status asthmaticus/
13 1 and 11 and 12
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extracted and sorted by country, study period, age, and 
their respective case number, sample size, and preva-
lence estimate. Extracts were grouped into data from writ-
ten questionnaires or video questionnaires, both includ-
ing data based on asthma diagnosis, and/or its symptoms 
(wheeze at rest, wheeze on exercise, nocturnal wheeze, 
nocturnal cough, or severe wheeze). For studies conduct-
ed on the same study site, population or cohort, the first 
chronologically published study was selected, with all ad-
ditional data from other studies added to that of the se-
lected paper.
For our analysis, weighted means of asthma symptoms 
were calculated (pooled from reported crude prevalenc-
es in individual studies) and expressed in percentages. 
Asthma prevalence estimates based on “current wheeze” 
(wheeze at rest- 12 months) have high sensitivities and 
specificities (1,17, 30); we therefore applied extracted val-
ues from this in our modeling. Mean age and prevalence 
were plotted on bubble graphs, and the fitted curve ex-
plaining the largest proportion of variance (best fit) was 
applied. The equation generated determined the preva-
lence of asthma in Africa at midpoints of the United Na-
tion population 5-year age-groups (for Africa) for the 
years 1990, 2000, and 2010.
RESUlTS
Systematic review
Our main search returned 790 studies; Medline (n = 246), 
EMBASE (n = 370), and Global Health (n = 174). After screen-
ing the titles for relevance (ie, asthma studies conducted 
primarily in an African population setting) and excluding 
duplicates, 147 studies were retained. 85 abstracts satisfied 
our selection criteria (ie, population-based studies provid-
ing numerical prevalence estimates of asthma). Applying 
the quality criteria (ie, studies with clear diagnostic criteria 
and survey methods), 43 studies were excluded. On hand 
searching reference lists of selected studies, further 3 stud-
ies were included, giving a total of 45 studies retained for 
the review (Figure 1).
Study characteristics
The 45 retained studies (12,20,31-73) covered most parts of 
Africa. South Africa (11 studies) and Nigeria (8 studies) had 
the highest publication outputs. Ethiopia and Kenya close-
ly followed with 6 and 5 studies respectively, while Algeria, 
Morocco, and Tunisia in North Africa had 4 studies each. 14 
studies were based on ISAAC guidelines and 31 non-ISAAC 
TAblE 2. Asthma terms and definitions
Terms Definition
Wheeze A high pitched whistling sound originating from obstructed airways (1). “Wheeze at rest-12 months” refers to the 
prevalence of wheeze in a person in the last 12 mo.
Asthma A chronic airway disease characterized by wheezing (a high pitched whistling sound originating from obstructed 
airways). Patient usually presents with chronic airways inflammation, bronchial hyper-responsiveness and reversible 
airflow obstruction, resulting in the recurrent attacks of wheeze, chest tightness, breathlessness, and occasionally 
cough and sputum production, all of varying severity and frequency from person to person (1,3,24,87). Asthma ever 
refers to cummulative prevalence of asthma in a person.
Asthma 
exacerbation
Also known as acute asthma. A sudden progressive episodes of shortness of breath, usually characterized by chest 
tightness, wheezing, cough, or sputum production (87)
Moderate asthma 
exacerbation
An event that, when recognized, should result in a temporary change in treatment, in an effort to prevent the exacer-
bation from being severe (24)
Severe asthma 
exacerbation
Events that require urgent action on the part of the patient and physician to prevent a serious outcome, such as 
hospitalization or death (24)
Severe asthma Uncontrolled asthma which can result in risk of frequent severe exacerbations (or death), and/or adverse reactions to 
medications, and/or chronic morbidity, including impaired lung function or reduced lung growth in children (24)
Asthma control Extent to which the various manifestation of asthma are reduced or removed by treatment (3,24)
Asthma 
diagnosis
GINA proposed a holistic approach involving detailed history, physical examination and spirometry. An increase in 
FEV1 of ≥12% and ≥200ml after a bronchodilator is indicative of reversible airflow limitation, which is consistent with 
asthma. Peak expiratory flow (PEF) with an improvement of 60l/min (or ≥20% of the pre-bronchodilator PEF) after a 
bronchodilator, or a diurnal variation in PEF of more than 20% (with twice daily readings more than 10%) may also be 
indicative of asthma. Other non-specific diagnostic tests include methacholine or histamine test, inhaled mannitol or 
exercise challenge, skin prick test and measurement of serum IgE (10,18)
*Abbreviations: FEV1 – forced expiratory volume in one second; GINA – Global Initiative for Asthma; IgE – immunoglobulin E; PEF – peak expiratory 
flow.
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guidelines, while 39 studies employed written question-
naires and 6 used video questionnaires (Table 3).
Most studies were conducted mainly on pediatric subjects, 
mostly defined as less than 15 years of age. For the age 
determination of subjects from most studies, birth certifi-
cates were usually employed, and in the absence of valid 
age-verification documents, historical landmarks were em-
ployed.
Many studies were conducted within one year (23 studies), 
sample sizes were mostly less than 1000 (mean 3243; me-
dian 2067), and study settings were predominantly mixed 
(urban and rural) (36 studies) (Table 3).
Prevalence estimates
We observed that the prevalence of asthma in some 
parts of Africa was comparable with that reported from 
surveys in high-income settings. From studies based on 
written questionnaires, “asthma ever” (cumulative preva-
lence of asthma) was highest in South Africa (53%, 5-12 
years) in 1997 (20), followed by Egypt (26.5%, 11-15 years) 
in 2005 (52), Nigeria (18.4%, 15-35 years) in 1995 (45), 
and Ethiopia (16.3%, >20 years) in 1997 (73). The lowest 
prevalence was recorded in Gambia (1.9%, >15 years) in 
1997 (69). “Current wheeze” (wheeze at rest-12-months) 
was consistently high in South Africa, 26.8% (13-14 years) 
in 1994, 23.9% (5-12 years) in 1998, and 20.3% (13-14 
years) in 2003 (20,31,62). From studies based on video 
questionnaires, “current wheeze” was highest in Morocco 
(12.9%, 6-7 years) in 2003 (31) and Tanzania (12.3%, 9-10 
years) in 2008 (35), with South Africa recording the low-
est prevalence (6.5%, 6-7 years) in 1995 and 2000, respec-
tively (31,62); there was no reported prevalence of “asth-
ma ever” from studies based on video questionnaires. 
However, from all studies, the pooled crude prevalences 
(weighted means) for “current wheeze” was 13.2% (male 
10.8%, female 13.1%, mean age 18.4 years), and “asthma 
ever” was 6.6% (male 6.7%, female 6.3%, mean age 22.9 
years) (Table 4). We observed that the pooled crude prev-
alences were consistently higher among urban dwell-
ers than rural dwellers. “Current wheeze” was 9.6% (male 
12.1%, female 7.0%, mean age 19.6 years) in urban set-
tings and 7.0% (male 5.5%, female 3.8%, mean age 17.5 
years) in rural settings. “Asthma ever” prevalence was 5.9% 
(male 5.6%, female 3.9%, mean age 22.9 years) and 5.1% 
(male 4.2%, female 3.1%, mean age 17.5 years) in urban 
and rural dwellers, respectively (Table 5).
Our modeling revealed an increasing prevalence of asth-
ma in Africa. We reported 34.1 million asthma cases 
(12.1%; 95% confidence interval [CI] 7.2-16.9) among 
children <15 years, 64.9 million asthma cases (11.8%; 
95% CI 7.9-15.8) among people aged <45 years, and 
TAblE 3. Asthma study distribution
Country: Number of studies
Algeria (32,36,37,44) 4
Burkina Faso (55,56) 2
Cameroon (31) 1
Cape Verde (72) 1
Congo Brazzaville (31) 1
Cote d’Ivoire (31,47,63) 3
DR Congo (31,61) 2
Egypt (52) 1
Ethiopia (12,31,32,53,71,73) 6
Gabon (31) 1
Gambia (69) 1
Ghana (41) 1
Guinea (31) 1
Kenya (31,39,40,59,68) 5
Madagascar (66) 1
Morocco (32,34,44,48) 4
Mozambique (49) 1
Nigeria (31-33,38,45,50,51,58) 8
Rwanda (57) 1
South Africa (20,31,32,42,43,54,60,62,65,67,70) 11
Sudan (31,32) 2
Tanzania (35) 1
Togo (31) 1
Tunisia (32,44,46,64) 4
Duration of study:
<1 y 23
1-3 y 16
>3 y 6
Sample size:
<1000 18
1001-3000 15
>3000 12
Study setting:
rural 3
urban 6
mixed 30
occupational 8
Study type:
based on ISAAC guidelines* 14
non-ISAAC guidelines 31
written questionnaire 39
video questionnaire 6
*ISAAC – The International Study of Asthma and Allergies.
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74.4 million cases (11.7%; 95% CI 8.2-15.3) in the total pop-
ulation in 1990. This increased to 41.3 million (12.9%; 95% 
CI 8.7-17.0) among children <15 years, 82.4 million (12.5%; 
95% CI 5.9-19.1) among people aged <45 years, and 94.8 
million (12.0%; 95% CI 5.0-18.8) in the total population in 
2000. In 2010, we estimated a total of 49.7 million asthma 
cases (13.9%; 95% CI 9.6-18.3) among children <15 years, 
102.9 million (13.8%; 95% CI 6.2-21.4) among people aged 
<45 years, and 119.3 million cases (12.8%; 95% CI 8.2-17.1) 
in the total population. We could not model the asthma 
prevalences separately for men and women due to very 
limited data (Figure 2 and Table 6).
DISCUSSION
This study, to our knowledge, provides the first systemat-
ic, data-derived and continent-wide estimates of asthma 
prevalence in Africa. Our modeling was based on pub-
lished epidemiological data on “current wheeze” preva-
lence, which has relatively higher sensitivity and specificity 
(1,17, 30), and also shows a significant association between 
age and asthma prevalence (74).
From the 2010 Institute for Health Metrics and Evaluation 
(IHME) global burden of disease estimates, chronic respira-
tory diseases overall burden has been decreasing globally 
FIGURE 1. Search strategy.
FIGURE 2. Age and prevalence distribution of asthma.
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and was responsible for about 4.7% of global disability ad-
justed life years (DALYs) in 2010, with asthma accounting 
for about one-fifth of this (75). However, the IHME report-
ed that DALYs from asthma increased by 4.6% (from 21.5 
to 22.5 million) between 1990 and 2010, while deaths de-
creased by 9.1% (from 0.38 to 0.34 million) over the same 
period globally (75,76). Concerns have been raised about 
the application of non-user friendly analytical methods, 
heavy statistical modeling, and difficulties in assessing the 
design methodologies and metrics used (77,78). In Africa 
however, the ISAAC study group, which mainly conduct-
ed epidemiological studies on asthma, reported increas-
ing prevalences of asthma across many study settings (31). 
For example, the prevalence of “current wheeze” (wheeze 
at rest-12 months) among children aged 13-14 years old 
in South Africa increased from 16.1% to 20.3% between 
1995 and 2002; Nigeria (West Africa) recorded an increase 
from 10.9% to 13.0%, Ethiopia (Horn of Africa) reported an 
increase from 6.2% to 9.1%, and Kenya (East Africa) an in-
crease from 13.9% to 18.0% (31,32). Our pooled crude prev-
TAblE 4. Weighted mean prevalence (pooled crude prevalences) of asthma symptoms from all studies
Overall study 
characteristics All Male Female
Study type Asthma indices
study 
period
mean
age 
(years)
data 
points
weighted mean 
% (95% confi-
dence interval)
data 
points
weighted mean 
% (95% confidence 
interval)
data 
points
weighted mean 
% (95% confi-
dence interval)
Written 
question-
naire
Asthma (ever) 1993-2008 22.9 50  6.6 (4.7-8.6) 6  6.7 (2.3-11.3) 6  6.3 (2.3-10.1)
Wheeze at rest (12 mo) 1993-2010 18.4 46 13.2 (11.6-14.9) 7 10.8 (5.9-15.8) 7 13.1 (7.6-18.4)
Wheeze at rest (ever) 1993-2010 14.7 12 17.7 (10.7-24.6) 2  9.1 (8.8-9.4) 2  6.2 (4.8-7.5)
Wheeze after exercise (12 
mo)
1995-2003 12.3 6 23.8 (15.9-31.7) 3 14.7 (4.4-33.8) 3 24.6 (11.0-38.2)
Wheeze after exercise 
(ever)
1993-2010 12.0 11  8.9 (5.1-12.8) 1  6.5 1  6.5
Nocturnal wheeze (12 mo) 1995-2005 15.4 6  4.9 (2.4-7.4) 1  9.1 1 10.0
Nocturnal wheeze (ever) - - -  - -  - -   -
Nocturnal cough (12 mo) 1995-2005 14.1 7 24.2 (18.3-30.0) 3 24.5 (11.5-37.4) 3 28.1 (13.2-43.2)
Nocturnal cough (ever) 1993 10.8 1  9.3 1 10.3 1  8.5
Severe wheeze (12 mo) 1993-2003 13.1 25  4.7 (3.7-5.6) 4  6.0 (4.6-7.4) 4  3.0 (0.8-5.2)
Severe wheeze (ever) 1993-2005 12.2 2  8.8 (5.9-11.6) 1  7.2 1  5.2
Video 
question-
naire
Wheeze at rest (12 mo) 1995-2008 13.0 9  9.7 (8.9-10.5) 1 11.7 1 13.0
Wheeze at rest (ever) 1995-2008 13.1 8 13.2 (12.4-14.0) 1 16 1 18.2
Wheeze after exercise (12 
mo)
1995-2008 12.9 8 15.5 (14.7-16.3) 1 19.1 1 11.5
Wheeze after exercise 
(ever)
1995-2008 13.0 7 20.4 (16.9-23.8) 1 28.7 1 15.4
Nocturnal wheeze (12 mo) 1995-2008 13.0 8  5.6 (4.8-6.4) 1  9.6 1  5.1
Nocturnal wheeze (ever) 1995-2008 13.0 8  8.1 (7.3-8.9) 1 14.9 1 19.2
Nocturnal cough (12 mo) 1995-2008 12.9 8 17.7 (16.8-18.5) 1 22.3 1 20.5
Nocturnal cough (ever) 1995-2008 13.0 7 24.6 (20.5-28.7) 1 31.9 1 34.6
Severe wheeze (12 mo) 1995-2008 13.0 9  6.8 (6.1-7.6) 1  5.3 1  3.9
Severe wheeze (ever) 1995-2008 13.1 8  9.6 (8.7-10.3) 1 12.8 1 13.0
TAblE 5. Rural and urban differences in asthma prevalences
Study characteristics All Male Female
Asthma 
indices
Study 
setting
study 
period
mean 
age
data 
points
weighted mean 
% (95% confi-
dence interval)
data 
points
weighted mean 
% (95% confi-
dence interval)
data 
points
weighted mean 
% (95% confi-
dence interval)
Asthma 
(ever)
Rural 1993-2008 17.5 6 5.1 (7.2-9.4) 2 4.2 (2.1-6.3) 2 3.1 (0.8-6.2)
Urban 1993-2010 22.9 7 5.9 (2.9-7.9) 1 5.6 1 3.9
Wheeze at 
rest (12 mo)
Rural 1993-2008 17.5 6 7.0 (2.5-11.5) 2 5.5 (1.4-12.4) 2 3.8 (1.5-12.9)
Urban 1993-2005 19.6 7 9.6 (3.9-15.2) 1 12.1 1 7
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alences (weighted means) also reflect this increase; we 
reported a prevalence of current wheeze (wheeze at rest- 
12-months) of 13.2% for both written and video question-
naires respectively. Furthermore, in keeping with findings 
from many studies, our pooled crude prevalences were 
consistently higher in urban than rural settings, suggest-
ing the effects of increasing urbanization on asthma preva-
lence in Africa (68,69,71).
From our modeling, we estimated a prevalence of 11.7% 
for asthma, totaling over 74 million people in 1990, and 
our 2010 prevalence was 12.8%, about 120 million peo-
ple. Public health experts have reported that increasing 
tobacco smoking without appropriate legislation and im-
plementation of relevant health promotional measures in 
many LMIC, especially in Africa, may also be responsible for 
the increase in asthma and other chronic respiratory dis-
eases’ burden in the region (2,75,79). In addition, the Global 
Burden of Asthma Report (GBAR) reported an increasing 
trend of asthma globally (4). GBAR estimated over 235 mil-
lion asthma cases worldwide, and about 50 million people 
living with asthma in Africa in 2004, with the highest preva-
lence (8.1%) recorded in South Africa (4). The authors argue 
that this increasing trend is expected due to rise in atopic 
sensitizations, allergic conditions, and changing patterns 
of environmental triggers (associated with environmental 
smoking exposure in children, population growth, and ur-
banization) in Africa over the last two decades (4). These 
factors may therefore be indicative of our reported high 
estimates.
While we aimed to provide an improved prevalence esti-
mate of asthma in Africa by carefully selecting high qual-
ity studies and applying simple analytical tools, there are 
however factors that could have affected our analysis. We 
thus entertain some degrees of uncertainties beyond the 
statistical confidence intervals generated, as variations in 
population settings, diagnostic criteria, sampling strate-
gies, and effects of other health determinants (beyond age 
of patients) are factors that need be considered. First, the 
variation in diagnostic criteria was observed across many 
study settings, with criteria based on asthma symptoms 
and ISAAC scores frequently used. This could have reflect-
ed in our reported high estimates of asthma in Africa, as 
there is evidence suggesting the ISAAC studies could have 
over-estimated the prevalence of asthma in Africa, as most 
study centers were mainly urban (1); and with ISAAC stud-
ies conducted mainly in the age range 13-14 years, it may 
still not be representative of all age-groups and the overall 
population (1,15). Second, while many studies were cross-
TAblE 6. Estimated asthma cases and prevalences based on current wheeze “wheeze at rest- 12 months” (based on bubble graph 
and United Nations population estimates for Africa)
Age range(years) 1990 estimates (000) 2000 estimates (000) 2010 estimates (000)
0-4 13405.19 15750.21 18946.71
5-9 11202.33 13526.59 16412.34
10-14  9461.50 12041.26 14306.87
15-19  7889.99 10494.98 12758.85
20-24  6497.60  8806.244 11373.60
25-29  5391.37  7149.79  9722.56
30-34  4457.30  5804.15  7946.30
35-39  3648.13  4823.34  6315.71
40-44  2977.33  3998.62  5075.31
45-49  2409.99  3260.32  4208.92
50-54  2009.40  2627.89  3490.57
55-59  1637.07  2064.60  2801.72
60-64  1282.71  1638.11  2172.14
65-69    919.99  1226.50  1581.25
70+ years  1162.36  1593.05  2201.80
Asthma cases (<15 y) 34069.02 41318.06 49665.92
Estimated prevalence (<15 y) 0.121 (95%CI: 0.072-0.169) 0.129 (95%CI: 0.088-0.170) 0.139 (95%CI: 0.096-0.183)
Asthma cases (<45 y) 64930.74 82395.18 102858.20
Estimated prevalence (<45 y) 0.118 (0.079- 0.158)* 0.125 (0.059- 0.191) 0.138 (0.062- 0.210)
Asthma cases (all)  74352.26 94805.65 119314.60
Estimated prevalence (all) 0.117 (0.082- 0.153) 0.119 (0.050- 0.188) 0.128 (0.082- 0.171)
*CI – confidence interval.
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sectional population-based, we also included studies con-
ducted in occupational settings; this is in view of reports re-
vealing that occupational asthma contributes significantly 
to the global burden of chronic respiratory diseases (73,80), 
and as these studies reported high prevalences, we under-
stand this could have increased our estimates, too. Third, 
despite included studies spreading across most parts of Af-
rica (24 countries in total), there are still many countries in 
Africa that are not included in the review; this reflects data 
gaps in the continent, and thus the generalizability of our 
estimates for Africa may need to be carefully examined. In 
addition, our overall sample size of 187 904 (from all stud-
ies) may not be a representative sample of the general Af-
rican population as there were more younger age groups. 
Finally, data on age- and sex-specific prevalence, including 
corresponding data on urban-rural settings, which are vital 
comparative indices in any study, were not always provid-
ed across many studies.
Management of asthma and public health challenges 
in Africa
It is important to note that chronic respiratory disease 
burden, including asthma has continued to increase in 
Africa due to lack of appropriate response from the gov-
ernments of many African countries (81,82). The national 
emphasis on asthma and relevant health messages have 
been sub-optimal, leading, in sequence, to poor aware-
ness of the burden, low prioritization, inadequate staffing 
and resources, and very low budget allocation. In fact, bud-
get allocation in many African countries mainly targets in-
fectious diseases; funds have been greatly biased toward 
HIV/AIDS, malaria, and tuberculosis, as these are the main 
government priorities (28,83). The GBAR authors reported 
that poor government allocation of funds for asthma re-
mained an important factor responsible for limited access 
to asthma medications, emergency health care, and other 
related health services in Africa (4). In addition, with tobac-
co companies still supporting many African governments, 
tobacco products’ sales have increased, and government 
funds have remained unavailable for research on asthma, 
as researches aimed at improving management of asthma 
may be against tobacco sales and consumption (22,69). 
This has greatly resulted in increased smoking (without a 
counter legislation) and a growing burden of asthma, es-
pecially among children in Africa over the last two decades 
(5,10). For example, Mackay et al reported that a compre-
hensive smoke free-legislation was important to achieving 
reduction in the asthma incidence among people without 
occupational exposure to environmental tobacco smoke; 
a reduction of 18.2% per year was observed in hospital ad-
missions in Scotland among children <15 years in 2009 
compared to a mean increase of admission of 5.2% per 
year before implementation of the legislation in 2006 (84)
The diagnosis and treatment of asthma still remains a ma-
jor challenge in Africa (16). Distinguishing asthma from 
other obstructive airway diseases has posed a clinical chal-
lenge to clinicians (3,5). Epidemiological data have shown 
that while asthma presents in episodes, usually among 
non-smokers and onsets before 40 years, chronic obstruc-
tive pulmonary disease (COPD) is associated with smok-
ers, people aged 40 years and above, with symptoms be-
ing persistent and progressive (1). In practice, asthmatics 
who smoke may have non-reversible airflow limitation, 
and some COPD patients may be non-smokers having re-
versible airflow limitation (85). In addition, many African 
countries have no standard protocols for the diagnosis 
and management of asthma (22); where these are avail-
able, guidelines are rarely implemented, and for the few 
implemented guidelines, treatment often does not reach 
the rural population that is mostly affected (26). In fact, in-
accessibility of health care services in many rural and re-
source-poor African settings often gives traditional healers 
undue significance in the management of many chronic 
diseases (22). The non-availability and unaffordability of 
inhaled steroids, and the relative non-adherence to these 
medications (when available) have also had large negative 
impact on the response to asthma in Africa. Studies have 
shown that about 50% of people adhere to prescribed 
medications (26,86), with reasons for non-adherence in-
cluding side-effects, dosing frequencies, and lack of patient 
education on their illness, need for treatment, and how to 
take medications (87). There are also inherent socio-cultur-
al misconceptions and individual values that need to be 
understood and addressed toward improving the accep-
tance and use of asthma medications (88), with continual 
public awareness and education being advocated, espe-
cially among parents of children with asthma (5,88).
Asthma is an important and increasing public health prob-
lem in Africa which receives inadequate priority and atten-
tion. With increasing urbanization, population aging, and 
adoption of western lifestyles in many African settings, 
these trends are set to continue in the near future. There 
is a need to identify and prioritize feasible strategies that 
can be adopted to promote the implementation of effec-
tive interventions that will address this increasing bur-
den in Africa. There is also a need for African national 
governments to also consider effects of associated 
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risk factors in public health policy planning on this topic 
with a focus on reducing environmental triggers, placing 
restrictions on tobacco adverts, and appropriately educat-
ing health care personnel and the public on the manage-
ment of the disease and the preventive measures.
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